These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 24810389

  • 1. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS.
    Eur Heart J; 2014 Oct 14; 35(39):2706-13. PubMed ID: 24810389
    [Abstract] [Full Text] [Related]

  • 2. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY, Yang ZG, Sun JY, Wen LY, Zhang G, Zhang S, Guo YK.
    Eur J Radiol; 2014 Apr 14; 83(4):665-72. PubMed ID: 24521610
    [Abstract] [Full Text] [Related]

  • 3. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
    Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ.
    Circulation; 2011 Jul 05; 124(1):40-7. PubMed ID: 21670234
    [Abstract] [Full Text] [Related]

  • 4. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW, Kim HK.
    Heart; 2015 Jun 05; 101(11):870-6. PubMed ID: 25897040
    [Abstract] [Full Text] [Related]

  • 5. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):220-8. PubMed ID: 19589434
    [Abstract] [Full Text] [Related]

  • 6. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO.
    Circ Cardiovasc Imaging; 2015 Dec 14; 8(12):. PubMed ID: 26659373
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.
    Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ.
    Circ Cardiovasc Imaging; 2012 Jul 14; 5(4):441-7. PubMed ID: 22563033
    [Abstract] [Full Text] [Related]

  • 8. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R, Lairez O, Boudou N, Méjean S, Lhermusier T, Dumonteil N, Berry M, Cognet T, Massabuau P, Elbaz M, Rousseau H, Galinier M, Carrié D.
    Arch Cardiovasc Dis; 2013 Jul 14; 106(8-9):440-7. PubMed ID: 23906680
    [Abstract] [Full Text] [Related]

  • 9. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T, Iwanaga Y, Yasuda M, Kawamura T, Miyaji Y, Morooka H, Miyazaki S.
    Int J Cardiovasc Imaging; 2016 Apr 14; 32(4):613-20. PubMed ID: 26589516
    [Abstract] [Full Text] [Related]

  • 10. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS.
    Am J Cardiol; 2008 Mar 01; 101(5):668-73. PubMed ID: 18308018
    [Abstract] [Full Text] [Related]

  • 11. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Chen X, Zhao S, Zhao T, Lu M, Yin G, Jiang S, Prasad S.
    Eur J Radiol; 2014 Feb 01; 83(2):297-302. PubMed ID: 24332848
    [Abstract] [Full Text] [Related]

  • 12. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ.
    Eur Heart J Cardiovasc Imaging; 2014 Oct 01; 15(10):1108-16. PubMed ID: 24819852
    [Abstract] [Full Text] [Related]

  • 13. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY.
    Circ Cardiovasc Imaging; 2013 May 01; 6(3):415-22. PubMed ID: 23549607
    [Abstract] [Full Text] [Related]

  • 14. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS.
    J Am Coll Cardiol; 2013 Jul 30; 62(5):449-57. PubMed ID: 23643593
    [Abstract] [Full Text] [Related]

  • 15. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy.
    Gruner C, Care M, Siminovitch K, Moravsky G, Wigle ED, Woo A, Rakowski H.
    Circ Cardiovasc Genet; 2011 Jun 30; 4(3):288-95. PubMed ID: 21511876
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.
    Güçlü A, Happé C, Eren S, Korkmaz IH, Niessen HW, Klein P, van Slegtenhorst M, Schinkel AF, Michels M, van Rossum AC, Germans T, van der Velden J.
    Eur J Clin Invest; 2015 Dec 30; 45(12):1252-9. PubMed ID: 26444145
    [Abstract] [Full Text] [Related]

  • 17. Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR.
    Florian A, Masci PG, De Buck S, Aquaro GD, Claus P, Todiere G, Van Cleemput J, Lombardi M, Bogaert J.
    JACC Cardiovasc Imaging; 2012 Jul 30; 5(7):702-11. PubMed ID: 22789938
    [Abstract] [Full Text] [Related]

  • 18. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J, Benson L, Rozenblyum E, Friedberg MK, Mertens L.
    J Am Soc Echocardiogr; 2014 Feb 30; 27(2):215-21. PubMed ID: 24325958
    [Abstract] [Full Text] [Related]

  • 19. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 20. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ.
    Circulation; 2008 Oct 07; 118(15):1541-9. PubMed ID: 18809796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.